Connect with us

Health

New insights into participation of underrepresented communities in Alzheimer’s clinical trials – News-Medical.Net

A significant hurdle in developing therapeutics and care models for Alzheimer’s disease that work for people of all ethnic and…

Published

on

Article feature image

A significant hurdle in developing therapeutics and care models for Alzheimer’s disease that work for people of all ethnic and racial backgrounds is the recruitment and retention of traditionally underrepresented groups in clinical trials. At the Alzheimer’s…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending